Bacterial load in gonococcal infections may guide treatment decisions, offering doctors new tools for managing asymptomatic ...

Despite being effective, PrEP uptake in Europe remains low due to issues like cost, access, and stigma, hindering its ...

A breakthrough study by Irish researchers pinpointed a biomarker for the early identification of the potentially deadly ...

States urged to act urgently as resistance to critical drugs hits alarming ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in ...

Attorneys representing four mothers -- two of whom reside in the Inland Empire -- challenging California's denial of ...

The epidemiology community is hoping a federal program to thwart infections among patients and health-care staff will emerge ...

The development of new antibiotics to treat superbugs and other bacterial infections is a global priority, with the rate of infections that cannot be treated with current antibiotics rising and ...

today announced the presentation of preclinical efficacy data on its second-generation fungerp candidate SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID ...

At the recent European Society of Clinical Microbiology and Infectious Diseases (ESCMID) meeting in Vienna, Longhorn Vaccines & Diagnostics LLC presented data on the neutralizing antibody responses of ...

VIENNA – Irish researchers presented data Saturday at the European Society of Clinical Microbiology and Infectious Diseases ...